PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1460.0
(-2.67%)
IDR 1460.0
(-2.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2043.48 Billion IDR | 1.71% |
| 2022 | 2009.13 Billion IDR | -3.68% |
| 2021 | 2085.9 Billion IDR | 4.99% |
| 2020 | 1986.71 Billion IDR | 8.57% |
| 2019 | 1829.96 Billion IDR | 8.74% |
| 2018 | 1682.82 Billion IDR | 2.56% |
| 2017 | 1640.88 Billion IDR | 7.15% |
| 2016 | 1531.36 Billion IDR | 11.27% |
| 2015 | 1376.27 Billion IDR | 11.33% |
| 2014 | 1236.24 Billion IDR | 3.88% |
| 2013 | 1190.05 Billion IDR | 10.73% |
| 2012 | 1074.69 Billion IDR | 15.77% |
| 2011 | 928.29 Billion IDR | 8.69% |
| 2010 | 854.1 Billion IDR | 9.0% |
| 2009 | 783.61 Billion IDR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2251.05 Billion IDR | 1.02% |
| 2024 Q1 | 2200.4 Billion IDR | 7.68% |
| 2024 Q2 | 2228.39 Billion IDR | 1.27% |
| 2023 Q4 | 2043.48 Billion IDR | 1.78% |
| 2023 Q1 | 2053.33 Billion IDR | 2.2% |
| 2023 Q2 | 2096.36 Billion IDR | 2.1% |
| 2023 FY | 2043.48 Billion IDR | 1.71% |
| 2023 Q3 | 2007.72 Billion IDR | -4.23% |
| 2022 Q1 | 2188.4 Billion IDR | 4.91% |
| 2022 Q2 | 2141.91 Billion IDR | -2.12% |
| 2022 Q3 | 2078.24 Billion IDR | -2.97% |
| 2022 Q4 | 2009.13 Billion IDR | -3.33% |
| 2022 FY | 2009.13 Billion IDR | -3.68% |
| 2021 Q1 | 2031.42 Billion IDR | 2.25% |
| 2021 Q4 | 2085.9 Billion IDR | -4.38% |
| 2021 Q3 | 2181.43 Billion IDR | 4.93% |
| 2021 Q2 | 2078.91 Billion IDR | 2.34% |
| 2021 FY | 2085.9 Billion IDR | 4.99% |
| 2020 Q4 | 1986.71 Billion IDR | 4.11% |
| 2020 Q1 | 1933.87 Billion IDR | 5.68% |
| 2020 Q2 | 2010.53 Billion IDR | 3.96% |
| 2020 FY | 1986.71 Billion IDR | 8.57% |
| 2020 Q3 | 1908.32 Billion IDR | -5.08% |
| 2019 FY | 1829.96 Billion IDR | 8.74% |
| 2019 Q2 | 1828.02 Billion IDR | 0.56% |
| 2019 Q4 | 1829.96 Billion IDR | -1.33% |
| 2019 Q1 | 1817.92 Billion IDR | 8.03% |
| 2019 Q3 | 1854.62 Billion IDR | 1.46% |
| 2018 Q3 | 1695.64 Billion IDR | 2.29% |
| 2018 Q2 | 1657.68 Billion IDR | -4.21% |
| 2018 FY | 1682.82 Billion IDR | 2.56% |
| 2018 Q1 | 1730.53 Billion IDR | 5.46% |
| 2018 Q4 | 1682.82 Billion IDR | -0.76% |
| 2017 Q1 | 1720.7 Billion IDR | 12.36% |
| 2017 Q2 | 1660.56 Billion IDR | -3.5% |
| 2017 Q3 | 1612.4 Billion IDR | -2.9% |
| 2017 Q4 | 1640.88 Billion IDR | 1.77% |
| 2017 FY | 1640.88 Billion IDR | 7.15% |
| 2016 FY | 1531.36 Billion IDR | 11.27% |
| 2016 Q4 | 1531.36 Billion IDR | -2.44% |
| 2016 Q2 | 1485.16 Billion IDR | -0.54% |
| 2016 Q3 | 1569.66 Billion IDR | 5.69% |
| 2016 Q1 | 1493.24 Billion IDR | 8.5% |
| 2015 Q3 | 1419.17 Billion IDR | -1.68% |
| 2015 FY | 1376.27 Billion IDR | 11.33% |
| 2015 Q4 | 1376.27 Billion IDR | -3.02% |
| 2015 Q1 | 1354.63 Billion IDR | 9.58% |
| 2015 Q2 | 1443.43 Billion IDR | 6.56% |
| 2014 Q1 | 1183.34 Billion IDR | -0.56% |
| 2014 Q3 | 1255.86 Billion IDR | 3.96% |
| 2014 Q4 | 1236.24 Billion IDR | -1.56% |
| 2014 Q2 | 1208.07 Billion IDR | 2.09% |
| 2014 FY | 1236.24 Billion IDR | 3.88% |
| 2013 Q2 | 1200.06 Billion IDR | 7.36% |
| 2013 Q3 | 1161.89 Billion IDR | -3.18% |
| 2013 Q4 | 1190.05 Billion IDR | 2.42% |
| 2013 FY | 1190.05 Billion IDR | 10.73% |
| 2013 Q1 | 1117.8 Billion IDR | 4.01% |
| 2012 Q4 | 1074.69 Billion IDR | 0.12% |
| 2012 FY | 1074.69 Billion IDR | 15.77% |
| 2012 Q3 | 1073.35 Billion IDR | 0.0% |
| 2011 FY | 928.29 Billion IDR | 8.69% |
| 2010 FY | 854.1 Billion IDR | 9.0% |
| 2009 FY | 783.61 Billion IDR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PT Merck Tbk | 957.81 Billion IDR | -113.349% |
| PT Phapros, Tbk | 1765.88 Billion IDR | -15.72% |
| PT Pyridam Farma Tbk | 1521.23 Billion IDR | -34.331% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3890.7 Billion IDR | 47.478% |
| PT Tempo Scan Pacific Tbk | 11315.73 Billion IDR | 81.941% |